CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Oral Estriol

Synthetics Biologics

Synthetic Biologics Reports 2011 Year End Financial Results

The pharmaceutical startup Synthetic Biologics Inc. (NYSE Amex: SYN) reported a larger loss for the year ended Dec. 31, but also a host of promising operational highlights.

WWJ Newsradio 950–04/01/2012

adeona2

Adeona Starts Phase II Trials Of New MS Drug

Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had started a Phase II clinical trial of Trimesta (oral estriol) for the treatment of cognitive dysfunction in multiple sclerosis in women.

WWJ Newsradio 950–01/19/2012